Ironwood Pharmaceuticals is trading 5.1% up today at $3.92, extending a multi-day rebound following a period of recent volatility.
- The move occurs in the absence of fresh company-specific news, earnings releases, or major regulatory filings reported this week.
- The upward momentum appears driven by broader positive sentiment across the biotechnology sector and risk assets rather than a distinct company catalyst.